Diagnosis and Management of Ocular Surface Disease - Mystery Versus Mastery
CME Activity Pricing
ASCRS Member Price: FREE
Nonmember Price: FREE
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from Johnson & Johnson Vision and Novartis.
ASCRS gratefully acknowledges the unrestricted educational grants received in support of the 2020 ASCRS Virtual Annual Meeting and Bonus CME Enduring Activities from Alcon Vision, LLC, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Inc., and Omeros Corporation.
This program explores how recognizing an early ocular surface disease diagnosis and treatment can impact your cataract and refractive surgical outcomes, dives into what diagnostic and therapeutic devices are available, and will provide the most up to date information on what treatment options are available.
Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Duration: 60 minutes
Activity Expiration Date: December 31, 2022
|Marjan Farid, MD||Francis Mah, MD|
|Brandon Ayres, MD||Preeya Gupta, MD||Christopher Starr, MD|
- Evaluate patients for OSD using the latest diagnostic and therapeutic devices
- Compare and contrast OSD treatment options and indications
- Recognize how early OSD diagnosis and treatment impacts cataract and refractive surgical outcomes